Cannabis use among adults 65 years and older has increased more than 10-fold over the past 2 decades, from just 0.4% in 2006 to 7% in 2023. Clinicians are now tasked with guiding cannabis use in older adults using evidence largely derived from younger populations, applied to products with inconsistent potency, and with minimal data specific to a vulnerable demographic.
CBD Gummies What They Do: A Practical Look at Effects, Evidence, and Everyday Use
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdEdiblesPharmacokineticsPatient EducationDosing Why This MattersCBD gummies represent the most popular consumer cannabis format, yet...
What are your questions about women and cannabis? – CNN
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Women'S HealthPharmacokineticsHormonesClinical PracticeResearch Gaps Why This MattersSex-based differences in cannabis metabolism, efficacy, and adverse...
7 THC Drink Brands To Celebrate 4/20 – Forbes
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic ThcEdiblesDosingBioavailabilityPatient Safety Why This MattersTHC beverages represent a rapidly expanding cannabis delivery method with...
A marijuana breathalyzer is one step closer to coming to market | The Independent
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic ImpairmentThcDiagnosticsSafetyPharmacokinetics Why This MattersCurrent cannabis impairment detection relies on blood or urine tests that...
THC levels in blood and urine are "unreliable" indicators of driving impairment – leafie
WHY IT MATTERS: Patients who use cannabis medicinally could face legal consequences for impaired driving based on biological thresholds that do not accurately reflect whether they were actually impaired at the time of driving. CLINICAL OVERVIEW: The relationship between THC concentration in biological fluids and actual driving impairment is far more complex than a simple number can capture. THC is highly lipophilic, meaning it distributes rapidly into tissues and does not remain in blood proportionally to psychoactive effect, which makes blood levels a poor proxy for functional intoxication.
Cannabis research: India to start human trials for medicinal marijuana – NewsBytes
WHY IT MATTERS: If India’s human trials produce strong safety and efficacy data, it could accelerate regulatory acceptance of medicinal cannabis across South and Southeast Asia, potentially expanding patient access in regions where options are currently very limited. CLINICAL OVERVIEW: India’s launch of human clinical trials for medicinal cannabis represents a significant regulatory and scientific shift for a country with historically strict drug policies. These trials will generate controlled safety and efficacy data across specific medical conditions, helping to establish evidence-based frameworks for potential therapeutic use.